Safety and Tolerability of Continuous Inhaled Iloprost Therapy for Severe Pulmonary Hypertension in Neonates and Infants
This is a single-center retrospective study to assess the safety and tolerability of continuous inhaled iloprost use as rescue therapy for refractory pulmonary hypertension (PH) in critically ill neonates and infants. A retrospective chart review was performed on 58 infants and data were collected a...
Saved in:
Main Authors: | Amit V. Krishnan (Author), Victoria Freniere (Author), Rakesh Sahni (Author), Diana P. Vargas Chaves (Author), Sankaran S. Krishnan (Author), Dimitrios Savva (Author), Usha S. Krishnan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhaled iloprost as part of combination therapy for persistent pulmonary hypertension of the newborn
by: Heru Samudro, et al.
Published: (2012) -
Inhaled Iloprost as a First-Line Therapy for Persistent Pulmonary Hypertension of the Newborn
by: Seung Hyun Kim, et al.
Published: (2019) -
The effect of perioperative inhaled iloprost on congenital heart disease with severe pulmonary arterial hypertension
by: Su Nam Kim, et al.
Published: (2010) -
Effect of inhaled iloprost on gas exchange in inhalation injury
by: Andrea Sikora Newsome, et al.
Published: (2017) -
Inhaled iloprost for the treatment of patient with Fontan circulation
by: Yong Hyun Kim, et al.
Published: (2014)